AIM: To investigate the growth inhibitory mechanism of NS-398, a selective cyclooxygenase-2 (COX-2) inhibitor, in two hepatocellular carcinoma (HCC) cell lines (HepG2 and Huh7). METHODS: HepG2 and Huh7 cells were treated with NS-398. Its effects on cell viability, cell proliferation, cell cycles, and gene expression were respectively evaluated by water-soluble tetrazolium salt (WST-1) assay, 4'-6-diamidino-2-phenylindole (DAPI) staining, flow cytometer analysis, and Western blotting, with dimethyl sulfoxide (DMSO) as positive control. RESULTS: NS-398 showed dose- and time-dependent growth-inhibitory effects on the two cell lines. Proliferating cell nuclear antigen (PCNA) expressions in HepG2 and Huh7 cells, particularly in Huh7 cells were inhibited in a time- and dose-independent manner. NS-398 caused cell cycle arrest in the G1 phase with cell accumulation in the sub-G1 phase in HepG2 and Huh7 cell lines. No evidence of apoptosis was observed in two cell lines. CONCLUSION: NS-398 reduces cell proliferation by inducing cell cycle arrest in HepG2 and Huh7 cell lines, and COX-2 inhibitors may have potent chemoprevention effects on human hepatocellular carcinoma.
AIM: To investigate the growth inhibitory mechanism of NS-398, a selective cyclooxygenase-2 (COX-2) inhibitor, in two hepatocellular carcinoma (HCC) cell lines (HepG2 and Huh7). METHODS: HepG2 and Huh7 cells were treated with NS-398. Its effects on cell viability, cell proliferation, cell cycles, and gene expression were respectively evaluated by water-soluble tetrazolium salt (WST-1) assay, 4'-6-diamidino-2-phenylindole (DAPI) staining, flow cytometer analysis, and Western blotting, with dimethyl sulfoxide (DMSO) as positive control. RESULTS:NS-398 showed dose- and time-dependent growth-inhibitory effects on the two cell lines. Proliferating cell nuclear antigen (PCNA) expressions in HepG2 and Huh7 cells, particularly in Huh7 cells were inhibited in a time- and dose-independent manner. NS-398 caused cell cycle arrest in the G1 phase with cell accumulation in the sub-G1 phase in HepG2 and Huh7 cell lines. No evidence of apoptosis was observed in two cell lines. CONCLUSION:NS-398 reduces cell proliferation by inducing cell cycle arrest in HepG2 and Huh7 cell lines, and COX-2 inhibitors may have potent chemoprevention effects on humanhepatocellular carcinoma.
Authors: R Hanif; A Pittas; Y Feng; M I Koutsos; L Qiao; L Staiano-Coico; S I Shiff; B Rigas Journal: Biochem Pharmacol Date: 1996-07-26 Impact factor: 5.858
Authors: D C Farrow; T L Vaughan; P D Hansten; J L Stanford; H A Risch; M D Gammon; W H Chow; R Dubrow; H Ahsan; S T Mayne; J B Schoenberg; A B West; H Rotterdam; J F Fraumeni; W J Blot Journal: Cancer Epidemiol Biomarkers Prev Date: 1998-02 Impact factor: 4.254
Authors: H Koga; S Sakisaka; M Ohishi; T Kawaguchi; E Taniguchi; K Sasatomi; M Harada; T Kusaba; M Tanaka; R Kimura; Y Nakashima; O Nakashima; M Kojiro; T Kurohiji; M Sata Journal: Hepatology Date: 1999-03 Impact factor: 17.425
Authors: T Hida; J Leyton; A N Makheja; P Ben-Av; T Hla; A Martinez; J Mulshine; S Malkani; P Chung; T W Moody Journal: Anticancer Res Date: 1998 Mar-Apr Impact factor: 2.480
Authors: Willscott E Naugler; Branden D Tarlow; Lev M Fedorov; Matthew Taylor; Carl Pelz; Bin Li; Jennifer Darnell; Markus Grompe Journal: Gastroenterology Date: 2015-05-29 Impact factor: 22.682
Authors: Rituparna Medda; Orestis Lyros; Jamie L Schmidt; Nebojsa Jovanovic; Linghui Nie; Benjamin J Link; Mary F Otterson; Gary D Stoner; Reza Shaker; Parvaneh Rafiee Journal: Microvasc Res Date: 2014-10-28 Impact factor: 3.514
Authors: Samiksha Bansal; Michael Berk; Naim Alkhouri; David A Partrick; John J Fung; Ariel Feldstein Journal: J Surg Res Date: 2013-07-27 Impact factor: 2.192
Authors: Si Hyun Bae; Seh Hoon Oh; Seung Kew Yoon; Joung Ah Park; Gi Dae Kim; Wonhee Hur; Jong Young Choi; Il Hoan Oh; Kun Ho Yoon Journal: Gut Liver Date: 2011-08-18 Impact factor: 4.519